Projects

Gravitate Health

Empowering and equipping Europeans with health information for active personal health management and adherence to treatment

Start:

01.2020

End: 

12.2025

Client: 

Datapharm Limited, European Commission (EC), European Federation of Pharmaceutical Industries and Associations (EFPIA)

Funding: 

Innovative Medicines Initiative 2 Joint Undertaking (IMI 2 JU)

GRAVITATE HEALTH is an integrated digital health information project. The Gravitate Health mission is to equip and empower citizens with digital information tools that make them confident, active, and responsive in their patient journey, specifically encouraging safe use of medicines for better health outcomes and quality of life.

GRAVITATE HEALTH aims to

  • develop an integrated, digital, user-centric health information solution with two-way communication for the public so that health information from a set of trusted sources is available and understandable (such as package leaflet content) and EHR-IPS (International Patient Summary).
  • promote adherence to treatment, safer use of medication (Pharmacovigilance), better health outcomes and quality of life through improved availability and understanding of health information from trusted sources & minimize risk through optimal use of available health information.

GRAVITATE HEALTH will deliver

  • an open source digital platform supporting G-Lens functionally, demonstrated in a number of testing scenarios, and
  • a White Paper with recommendations on realistic strategies to strengthen access, understanding and future use of digital services like ePIs as a tool for Risk Minimization.

Gravitate Health services and G-lens will be developed and tested within the project, using an evaluation framework to test the efficiency, efficacy, and safety of Gravitate-Health services.

The Gravitate Health is a public ““ private partnership with 39 members from Europe and the US, co-led by University of Oslo (coordinator) and Pfizer (industry lead), funded by the Innovative Medicines Initiative (IMI) ““ a joint undertaking of the European Commission, the European Federation of Pharmaceutical Industries and Associations (EFPIA), IMI Associated Partners.